Eleonora Dore

Dr. Eleonora Dore

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Metabolic Engineering
Verified
Journal Article
Open access
VDVasil D'AMbrosio
Vasil D'AMbrosio
EDEleonora Dore
Eleonora Dore
RBRoberto Di Blasi
Roberto Di Blasi
MBMarcel van Den Broek
Marcel van Den Broek
SSSuresh Sudarsan
Suresh Sudarsan
MJMichael K. Jensen
Michael K. Jensen
Engineering living cells for production of chemicals, enzymes and therapeutics can burden cells due to use of limited native co-factor availability and/or expression burdens, totalling a fitness deficit compared to parental cells encoded through long evolutionary trajectories to maximise fitness. Ultimately, this discrepancy puts a selective pressure against fitness-burdened engineered cells under prolonged bioprocesses, and potentially leads to complete eradication of high-performing engineered cells at the population level. Here we present the mutation landscapes of fitness-burdened yeast cells engineered for vanillin-β-glucoside production. Next, we design synthetic control circuits based on transcriptome analysis and biosensors responsive to vanillin-β-glucoside pathway intermediates in order to stabilize vanillin-β-glucoside production over ~55 generations in sequential passage experiments. Furthermore, using biosensors with two different modes of action we identify control circuits linking vanillin-β-glucoside pathway flux to various essential cellular functions, and demonstrate control circuits robustness and almost 2-fold higher vanillin-β-glucoside production, including 5-fold increase in total vanillin-β-glucoside pathway metabolite accumulation, in a fed-batch fermentation compared to vanillin-β-glucoside producing cells without control circuits.

1 April 2026 in Catalysts
Verified
Journal Article
Open access
PDF file
SPStefania Patti
Stefania Patti
SRSimone Antonio De Rose
Simone Antonio De Rose
MIMichail Isupov
Michail Isupov
IKIlya Kublanov
Ilya Kublanov
IAIlaria Magrini Alunno
Ilaria Magrini Alunno
Daniela MontiDaniela Monti
Daniela Monti
2-Phosphoglycerate kinase (2PGK) and cyclic 2,3-diphosphoglycerate synthase (cDPGS) are key enzymes involved in the biosynthesis of cyclic 2,3-diphosphoglycerate (cDPG), an extremolyte known to stabilize proteins in hyperthermophilic Archaea. Using bioinformatics approaches, two candidate genes for each enzyme were identified from a range of thermophilic bacterial and archaeal genomes and metagenomes. Significantly, one gene pair derived from the Taman mud volcano metagenome represents the first indication of a bacterial cDPG biosynthesis pathway. The recombinant expression and purification of these enzymes paved the way to their biochemical and structural characterization. One 2PGK candidate displayed predominant ATPase activity, while the newly identified cDPGS variants demonstrated cDPG synthase activity. Moreover, one of the latter biocatalysts, Ts-cDPGS from the hyperthermophilic archaeon Thermococcus sibiricus, demonstrated a notable thermostability and its 3D structure was resolved at a resolution of 2.2 Å. These findings broaden our understanding of extremophilic enzyme systems and lay the foundation for biotechnological applications involving extremolyte production.